| Published Application/Species/Sample/Dilution | Reference |
|---|
- western blot; human; fig 6b
| Agrawal P, Fontanals Cirera B, Sokolova E, Jacob S, Vaiana C, Argibay D, et al. A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis. Cancer Cell. 2017;31:804-819.e7 pubmed publisher |
- immunohistochemistry; rat; 1:50; fig 2
- western blot; rat; fig 6
| Pellet Many C, Mehta V, Fields L, Mahmoud M, Lowe V, Evans I, et al. Neuropilins 1 and 2 mediate neointimal hyperplasia and re-endothelialization following arterial injury. Cardiovasc Res. 2015;108:288-98 pubmed publisher |
- immunocytochemistry; human; fig 2
- western blot; human; fig 1
| Ji T, Guo Y, Kim K, McQueen P, Ghaffar S, Christ A, et al. Neuropilin-2 expression is inhibited by secreted Wnt antagonists and its down-regulation is associated with reduced tumor growth and metastasis in osteosarcoma. Mol Cancer. 2015;14:86 pubmed publisher |
| Epis M, Giles K, Candy P, Webster R, Leedman P. miR-331-3p regulates expression of neuropilin-2 in glioblastoma. J Neurooncol. 2014;116:67-75 pubmed publisher |
| Smolkin T, Nir Zvi I, Duvshani N, Mumblat Y, Kessler O, Neufeld G. Complexes of plexin-A4 and plexin-D1 convey semaphorin-3C signals to induce cytoskeletal collapse in the absence of neuropilins. J Cell Sci. 2018;131: pubmed publisher |
| Po A, Silvano M, Miele E, Capalbo C, Eramo A, Salvati V, et al. Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma. Oncogene. 2017;36:4641-4652 pubmed publisher |
| Dutta S, Roy S, Polavaram N, Stanton M, Zhang H, Bhola T, et al. Neuropilin-2 Regulates Endosome Maturation and EGFR Trafficking to Support Cancer Cell Pathobiology. Cancer Res. 2016;76:418-28 pubmed publisher |
| Nakayama H, Bruneau S, Kochupurakkal N, Coma S, Briscoe D, Klagsbrun M. Regulation of mTOR Signaling by Semaphorin 3F-Neuropilin 2 Interactions In Vitro and In Vivo. Sci Rep. 2015;5:11789 pubmed publisher |
| Keck B, Wach S, Taubert H, Zeiler S, Ott O, Kunath F, et al. Neuropilin-2 and its ligand VEGF-C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patients. Int J Cancer. 2015;136:443-51 pubmed publisher |
| Sabag A, Bode J, Fink D, Kigel B, Kugler W, Neufeld G. Semaphorin-3D and semaphorin-3E inhibit the development of tumors from glioblastoma cells implanted in the cortex of the brain. PLoS ONE. 2012;7:e42912 pubmed publisher |
| Bielenberg D, Seth A, Shimizu A, Pelton K, Cristofaro V, Ramachandran A, et al. Increased smooth muscle contractility in mice deficient for neuropilin 2. Am J Pathol. 2012;181:548-59 pubmed publisher |
| Vintonenko N, Pelaez Garavito I, Buteau Lozano H, Toullec A, Lidereau R, Perret G, et al. Overexpression of VEGF189 in breast cancer cells induces apoptosis via NRP1 under stress conditions. Cell Adh Migr. 2011;5:332-43 pubmed publisher |
| Herzog B, Pellet Many C, Britton G, Hartzoulakis B, Zachary I. VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation. Mol Biol Cell. 2011;22:2766-76 pubmed publisher |
| Wu F, Zhou Q, Yang J, Duan G, Ou J, Zhang R, et al. Endogenous axon guiding chemorepulsant semaphorin-3F inhibits the growth and metastasis of colorectal carcinoma. Clin Cancer Res. 2011;17:2702-11 pubmed publisher |
| Stine M, Wang C, Moriarty W, Ryu B, Cheong R, Westra W, et al. Integration of genotypic and phenotypic screening reveals molecular mediators of melanoma-stromal interaction. Cancer Res. 2011;71:2433-44 pubmed publisher |
